American Journal of Physiology: Lung Cellular and Molecular Physiology 1993: Vol 8 Index

11 Pages·1993·2.8 MB·English

Subject Index to Volume 8
A subacute exposure, genetic control, tion intensity, muscle preload
A549 cells, alveolar type II epithelial cells, L15 (horse), L269
tone, modulation by hypoxia, role of
phospholipase Ao, characterization,
L261 Ca** entry (pig), L284 B
Albumin, gastrin-releasing peptide and an-
Acetylcholine Bacteremia, postoperative, ED,-containing
alogues, nasal mucosal secretion,
chronic hydrogen peroxide exposure and, cellular fibronectin release, lung
L345
airway smooth muscle, L566 lymph (sheep), L66
Alkaline phosphatase, gastrin-releasing
electrically evoked release, N-type cal- Benzamil, amiloride-sensitive Na* chan-
peptide and analogues, nasal mu-
cium channel mediation of, trachea nels, fetal lung epithelial cells, L357
cosal secretion, L345
(guinea pig), L581 Bile duct, biliary cirrhosis, increased pul-
Alveolar cells
release from airway cholinergic nerves, monary vascular resistance, role of
epithelial barrier properties, asymmetric
stimulation intensity, muscle pre- thromboxane A», L245
effects, hydrogen peroxide, L308
load (horse), L269 Bleomycin, -stimulated alveolar macro-
type II
Acid-base balance, calcium transients in phages, transforming growth factor-
cell-specific posttranslational process-
type II alveolar epithelial cells, in- 8 expression and secretion, L36
ing, SP-B, L290
duction by pH, L448 Blood vessels, tracheal, steroid-induced
increased surfactant internalization,
Actinomycin D, biphasic glucocorticoid suppression of adhesion, reversal by
microporous membranes, L300
regulation, pulmonary SP-A, inhibi- peptidase inhibitors, L316
neutrophil adherence, cell surface car-
tory process, L236 Bombesin
bohydrates, L391
Adenine, nucleotide degradation, ischemic contractile effect, gastrin-releasing pep-
phospholipase A», characterization,
lung tissue, L329 tide receptors, lung, L80
L261
Adenosine, inhibition induced by, vagal gastrin-releasing peptide and analogues,
regulation of phosphatidylcholine syn-
motoneuron excitability, receptor nasal mucosal secretion, L345
thesis, L575
subtype, L124 Bone cells: see Osteoclasts
serum-free cell culture, fetal lung,
Adenosine monophosphate, cyclic Brain, lungs with hypoxic pulmonary hy-
L504
ATP and, synthesis of surfactant protein pertension, PDGF A- and B-chain
stimulation of chemotaxis by SP-A,
A, lung, L431 genes, L100
macrophages, L338
inhibition of IL-1-induced IL-6 produc- Bronchi
Amiloride
tion, lung fibroblasts, L253 modulation of airway tone by hypoxia,
oxidant injury, alteration of barrier func-
responsiveness of fetal lung, modulation role of Ca** (pig), L284
tion, tracheal epithelium (ferret),
of differentiation, oxygen, L465 L165 neural relaxation, nitric oxide synthase,
Adenosine triphosphate sodium channels sensitive to, fetal lung L425
activation of phospholipase D, surfactant epithelial cells, L357 Bronchial epithelial cells, fibrinolytic ac-
secretagogues, type II pneumocytes, Amino acids, transport, pulmonary artery tivity, asbestos exposure, L276
L133 endothelial cells (pig), L351 Bronchiectasis, interleukin 8 as chemo-
adenine nucleotide degradation, ischemic Angiotensin-converting enzyme, steroid-in- attractant, sputum, chronic inflam-
lung tissue, L329 duced suppression of adhesion, re- matory airway diseases, L413
cyclic AMP and, synthesis of surfactant versal by peptidase inhibitors, tra- Bronchioles, differentiation, secretory
protein A, lung, L431 cheal blood vessels, L316 product expression during (rabbit,
Adhesion, endothelial, hydrogen peroxide- Antioxidant enzymes rat), L543
induced increase, ICAM-1 activa- alveolar epithelial barrier properties, Bronchoalveolar lavage, susceptibility to
tion, L406 asymmetric properties, hydrogen ozone-induced inflammation, sub-
Air-liquid interface culture, enhanced so- peroxide, L308 acute exposure, genetic control, L15
dium transport and, airway, L560 expression, ovary cells (hamster), L598 Buthionine sulfoximine, variable glutathi-
Airway variable glutathione levels and expres- one levels, antioxidant enzymes,
cholinergic nerves, acetylcholine release, sion, endothelial cells, L482 endothelial cells, L482
stimulation intensity and muscle Arachidonic acid
preload (horse), L269 A23187-mediated activation of, serine Cc
epithelium esterase role in, pulmonary endothe- Calcium
enhanced sodium transport in, L560 lium, L538 cytosolic, acute hypoxia, pulmonary arte-
fluid movement and ion transport, phospholipase Az, alveolar type II epi- rial myocytes, L323
modulation by dexamethasone, L376 thelial cells, characterization, L261 inositol trisphosphate, norepinephrine-
modulation of inherent tone, phosphodi- transcellular eicosanoid synthesis, cocul- induced pulmonary arterial contrac-
esterase isozymes, L458 tures, alveolar epithelial cells and tion, L160
morphometry, secretory product expres- macrophages, L438 mobilization, muscarinic cholinergic
sion (rabbit, rat), L543 L-Arginine, transport, pulmonary artery stimulation, single airway smooth
neural relaxation of bronchi, nitric oxide endothelial cells (pig), L351 muscle, L496
synthase inhibitor, L425 Artery, pulmonary, endothelium, monocro- transients in type II alveolar epithelial
smooth muscle taline pyrrole-induced DNA cross- cells, induction by pH, L448
mode of activation of eosinophils, linking (pig), L517 Calcium channels, N-type, acetylcholine
L475 Asbestos, exposure, increased bronchial ep- release and, trachea (guinea pig),
muscarinic cholinergic stimulation, ithelial cell fibrinolytic activity, L581
calcium mobilization, L496 L276 Calcium currents, pulmonary and mesen-
substrates, myosin phosphorylation and A23187: see Calcium ionophore teric arterial myocytes, ionic cur-
stress in, L553 ATP-ribosylation, PAF, pulmonary hemo- rents, primary culture and subcul-
susceptibility to ozone-induced inflam- dynamic alterations (pig), L213 ture, L107
mation Autoreceptors, acetylcholine release from Calcium ionophore, phospholipase A, acti-
separate loci control responses, L21 airway cholinergic nerves, stimula- vation mediated by, serine esterase
L619
L620 SUBJECT INDEX TO VOLUME 8
Calcium ionophore (continued) Chloride channels, low-conductance, IEC-6 Diacylglycerol, airway smooth muscle,
role in, pulmonary endothelium, and CF nasal cells, CFTR expres- muscarinic cholinergic stimulation,
L538 sion, L229 calcium mobilization, L496
Calcium ions Cholinergic innervation, development of, Dibutyryl adenosine 3’, 5’-cyclic mono-
differences in mobilization, muscarinic trachea (piglet), L606 phosphate, cAMP inhibition, IL-1-
agonists, tracheal smooth muscle, Chromatography, high-performance liquid, induced IL-6 production, lung fibro-
L53 acetylcholine release, airway cholin- blasts, L253
entry, modulation of airway tone, hy- ergic nerves (horse), L269 Diethylmaleate, variable glutathione levels,
poxia (pig), L284 Cirrhosis, biliary, increased pulmonary antioxidant enzymes, endothelial
Calphostin C, activation, pulmonary artery vascular resistance, role of throm- cells, L482
endothelial protein kinase C, L7 boxane A», L245 Diotanoglycerol, activation, pulmonary ar-
cAMP: see Adenosine monophosphate, Clara cells, differentiation, secretory prod- tery endothelial protein kinase C,
cyclic uct expression during (rabbit, rat), tumor necrosis factor-a, L7
Capsaicin, steroid-induced suppression of L543 Diphenylamine-2-carboxylate, oxidant in-
adhesion, reversal by peptidase in- Collagen jury, tracheal epithelium (ferret),
hibitors, tracheal blood vessels, mediation of endothelial injury, neutro- L165
L316 phil adherence to extracellular ma- DNA, monocrotaline pyrrole-induced
Captopril, steroid-induced suppression of trix, L401 cross-linking, pulmonary artery en-
adhesion, reversal by peptidase in- protein synthesis in pulmonary arteries, dothelium (pig), L517
hibitors, tracheal blood vessels, exposure to hypoxia, L74
L316 stimulation of chemotaxis by SP-A, al-
Carbachol, airway smooth muscle, musca- veolar macrophages, L338 Edema, pulmonary, neutrophil-activating
rinic cholinergic stimulation, cal- Complements, stimulation of chemotaxis peptide-2, heart failure or ARDS,
cium mobilization, L496 by SP-A, alveolar macrophages, L490
Carbohydrates L338 EDRF: see Endothelium-derived relaxing
cell surface, modulation of neutrophil Compound 48/80, histamine release from factor
adherence, alveolar type II cells, mast cells, inhibition by heparin, Eicosanoids
L391 L387 PAF, pulmonary hemodynamic altera-
stimulation of chemotaxis by SP-A, al- Copper, -Zn superoxide dismutase, cell cy- tions (pig), L213
veolar macrophages, L338 cling and exposure to hyperoxia, phospholipase Ao, alveolar type II epi-
Cardiopulmonary system, alterations dur- vascular cells, L365 thelial cells, characterization, L261
ing coinfusion of TNF-a and IL-1la, Coupling, receptor-effector, smooth muscle TNF-a and IL-1le coinfusion, cardiopul-
PAF receptor antagonism (pig), guanine nucleotides, inhibition of monary alterations, PAF receptor
oxidative energy production, L1 antagonism (pig), L175
L175
CTP-phosphocholine cytidylyltransferase, transcellular synthesis in cocultures, al-
Catalase
regulation of phosphatidylcholine veolar epithelial cells, macrophages,
alveolar epithelial barrier properties,
synthesis, alveolar type II cells, L438
asymmetric properties, hydrogen
L575 Elastin, protein synthesis in pulmonary ar-
peroxide, L308
Cycloheximide, biphasic glucocorticoid reg- teries, exposure to hypoxia, L74
chronic hydrogen peroxide exposure and,
ulation, pulmonary SP-A, inhibitory Electrical field, stimulation intensity and
airway smooth muscle, L566 process, L236 muscle preload, acetylcholine re-
hydrogen peroxide-induced increase, Cyclooxygenase, activation of tracheal lease, airway cholinergic nerves
endothelial adhesiveness, ICAM-1 smooth muscle responsiveness, (horse), L269
activation, L406 FMLP-treated HL-60 cells, neutro- Endopeptidase 24.11, steroid-induced
oxidant injury, alteration of barrier func- phils, L222 suppression of adhesion, reversal by
tion, tracheal epithelium (ferret), Cystic fibrosis peptidase inhibitors, tracheal blood
L165 interleukin 8 as chemoattractant, spu- vessels, L316
variable glutathione levels, antioxidant tum, chronic inflammatory airway Endothelial cells
enzymes, endothelial cells, L482 diseases, L413 Cu,Zn superoxide dismutase, cell cycling,
CD18, mediation of endothelial injury, nasal cells expression CFTR, low-con- exposure to hyperoxia, L365
neutrophil adherence to extracellu- ductance chloride channels, IEC-6 pulmonary, serine esterase and regula-
lar matrix, L401 cells, L229 tion of phospholipase A, in, L538
Cell culture tracheal gland cells, hypersecretion and pulmonary artery, L-arginine transport
cystic fibrosis tracheal gland cells, hy- insensitivity, neurotransmitters, L93 (pig), L351
persecretion and insensitivity, neu- Cytokines, TNF-a and IL-1la coinfusion, Endothelium
rotransmitters, L93 cardiopulmonary alterations, PAF adhesiveness, hydrogen peroxide-induced
monocrotaline pyrrole-induced DNA receptor antagonism (pig), L175 increase, ICAM-1 activation, L406
cross-linking, pulmonary artery en- Cytosol, calcium, acute hypoxia, pulmo- ischemic pulmonary venules, hydraulic
dothelium (pig), L517 nary arterial myocytes, L323 conductivity, L382
serum-free, type II cell differentiation, mediation of injury, neutrophil adher-
fetal lung, L504 D ence, extracellular matrix, L401
Cell cycle, exposure to hyperoxia and, Cu, Dazoxiben, biliary cirrhosis, increased pul- pulmonary artery, monocrotaline pyr-
Zn superoxide dismutase, vascular monary vascular resistance, role of role-induced DNA cross-linking
cells, L365 thromboxane A», L245 (pig), L517
Chemoattractant, interleukin 8, sputum, Deferoxamine mesylate, oxidant injury, al- Endothelium-derived relaxing factor,
chronic inflammatory airway dis- teration of barrier function, tracheal suppression, vasoconstrictor mecha-
eases, L413 epithelium (ferret), L165 nism, hypertensive lung, L587
Chemotaxis Development: see also Growth Energy, oxidative, inhibition of production,
interleukin 8 as chemoattractant, spu- lung guanine nucleotides and receptor-ef-
tum, chronic inflammatory airway regulation of phosphatidylcholine syn- fector coupling, L1
diseases, L413 thesis, type II cells, L575 Eosinophils, mode of activation, tracheal
monocyte, alveolar macrophage produc- secretory product expression (rabbit, smooth muscle contraction, L475
tion, transforming growth factor-8 rat), L543 Epidermal growth factor, tubule formation,
expression, L36 Dexamethasone, modulation of ion trans- three-dimensional collagen lattice,
stimulation by surfactant protein A, al- port, fluid movement across airway surface respiratory epithelial cells,
veolar macrophage, L338 epithelium, L376 L183
SUBJECT INDEX TO VOLUME 8 L621
Epithelial cells G dium and proton pump, alveolar
alveolar macrophages, L523
calcium transients in type II, induc- Gastrin-releasing peptide Hydrogen peroxide
tion by pH, L448 analogues and, nasal mucosal secretion, asymmetric effects, alveolar epithelial
L345
transcellular eicosanoid synthesis, barrier properties, L308
macrophages, L438 receptors, contractile effect of bombesin, chronic exposure, airway smooth muscle,
lung, L80
fetal lung, amiloride-sensitive Na* chan- hydroxyl radical effects, L566
Genes
nels, L357 -induced increase, endothelial adhesive-
respiratory cystic fibrosis gene product, low-con- ness, ICAM-1 activation, L406
quantitative evaluation, gene expres- ductance chloride channels, IEC-6 O.-dependent modulation, lactate, pul-
sion, L199 and CF nasal cells, L229 monary artery tone, L141
tubule formation, three-dimensional 70-kDa heat-shock, heat stress regula- oxidant injury, alteration of barrier func-
tion of, L533
collagen lattice, L183 tion, tracheal epithelium (ferret),
modulation of differentiation by oxygen,
type II cell differentiation, serum-free L165
cAMP responsiveness, fetal lung,
cell culture, fetal lung, L504 Hydroxyl radical, chronic hydrogen perox-
L465
Epithelium ide exposure and, airway smooth
airway, fluid movement and ion trans- PDGF A- and B-chain, hypoxic pulmo- muscle, L566
nary hypertension, lung, L100
port, modulation by dexamethasone, Hyperoxia, cell cycling, Cu,Zn superoxide
L376 quantitative evaluation, respiratory epi- dismutase, vascular cells, L365
thelial cells, L199
alveolar, type II pneumocyte hypertro- Hypertension
Genetics
phy, partial pneumonectomy, L153 pulmonary
separate loci control responses, suscepti-
IEC-6 and CF nasal cells expressing PDGF A- and B-chain genes, lung,
bility, ozone-induced inflammation,
CFTR, low-conductance chloride L100
L21
channels, L229 vasoconstrictor suppression by EDRF,
susceptibility to ozone-induced inflam-
tracheal, alteration of barrier function, L587
mation, subacute exposure, L15
oxidant injury (ferret), L165 pulmonary artery, exposure to hypoxia,
Glucagon, -like peptide-1 receptors, solu-
Extracellular matrix protein synthesis, L74
bilization, lung, L146
neutrophil adherence, mediation, endo- pulmonary artery endothelium, mono-
Glucocorticoids, biphasic regulation, pul-
thelial injury, L401 crotaline pyrrole-induced DNA
monary SP-A, inhibitory process,
three-dimensional collagen lattice, tu- cross-linking (pig), L517
L236
bule formation, surface respiratory Hypertrophy, type II pneumocyte, partial
Glutathione, variable levels and expres-
epithelial cells, L183 pneumonectomy, L153
sion, antioxidant enzymes, endothe-
Hypoxanthine-xanthine oxidase, variable
lial cells, L482
glutathione levels, antioxidant en-
Glutathione peroxidase, variable glutathi-
zymes, endothelial cells, L482
one levels, antioxidant enzymes,
Hypoxia
Fetus endothelial cells, L482
acute, cytosolic calcium, pulmonary arte-
lung G proteins
rial myocytes, L323
modulation of differentiation by oxy- PAF, pulmonary hemodynamic altera-
exposure of pulmonary arteries, protein
gen, cAMP responsiveness, L465 tions (pig), L213
synthesis, L74
trafficking of surfactant protein A, or- muscarinic receptor subtypes and, tra-
-induced pulmonary arterial contraction,
gan culture, L27 chea (piglet), L606
inositol trisphosphate, norepineph-
type II cell differentiation, serum-free Growth: see also Development
rine, L160
cell culture, L504 immature lung, transplantation into
inhibition of oxidative energy produc-
lung epithelial cells, amiloride-sensitive adult recipient, L60
tion, smooth muscle guanine nucleo-
Na* channels, L357 Guanine nucleotides, smooth muscle, re-
tides, receptor-effector coupling, L1
pulmonary SP-A, biphasic glucocorticoid ceptor-effector coupling, inhibition
modulation of airway tone, role of Ca**
regulation, inhibitory process, L236 of oxidative energy production, L1
entry (pig), L284
Fibroblasts, [L-1-induced IL-6 production, Guanosine monophosphate, cyclic, O.-de-
pulmonary hypertension, PDGF A- and
inhibition by cAMP, L253 pendent modulation, lactate, pulmo-
B-chain genes, lung, L100
Fibronectin, ED,-containing, release into nary artery tone, L141
reduction of potassium currents, pulmo-
lung lymph, vascular injury with Guanylate cyclase, O.-dependent modula-
nary arterial myocytes, L116
postoperative bacteremia (sheep), tion, lactate, pulmonary artery tone,
L66 L141
Fibrosis, pulmonary, alveolar macrophage
production, transforming growth I
factor-8 expression, L36
H
Fluid, movement across airway epithelium, IEC-6 cells, low-conductance chloride
modulation by dexamethasone, ion Heart, congestive failure, neutrophil-acti- channels, expression of CFTR, L229
transport, L376 vating peptide-2, pulmonary edema, Immunofluorescence, amiloride-sensitive
Flux, ischemic pulmonary venules, hy- L490 Na* channels, fetal lung epithelial
draulic conductivity, L382 Heat, stress, regulation of 70-kDa heat- cells, L357
FMLP, -treated HL-60 cells and neutro- shock gene, L533 Immunoprecipitation, stimulation of sur-
phils, activation, tracheal smooth Heme oxygenase, variable glutathione lev- factant protein A synthesis, ATP
muscle responsiveness, L222 els, antioxidant enzymes, endothe- and cyclic AMP, lung, L431
Fura-2 lial cells, L482 Indomethacin
airway smooth muscle, muscarinic cho- Heparin, inhibition of pulmonary release, chronic hydrogen peroxide exposure and,
linergic stimulation, calcium mobili- mast cells, L387 airway smooth muscle, L566
zation, L496 Histamine, release from mast cells, inhibi- PAF, pulmonary hemodynamic altera-
calcium transients in type II alveolar ep- tion by heparin, L387 tions (pig), L213
ithelial cells, induction by pH, L448 HL-60 cells, FMLP-treated, activation, Infection, gram-negative, TNF administra-
increased cytosolic calcium, acute hy- tracheal smooth muscle responsive- tion, superoxide production and pro-
poxia, pulmonary arterial myocytes, ness, L222 tein kinase C in alveolar macro-
L323 HPLC: see Chromatography, high-per- phages, L43
Furosemide, oxidant injury, alteration of formance liquid Inflammation
barrier function, tracheal epithelium Hydrogen-adenosine triphosphatase, respi- ozone-induced
(ferret), L165 ratory burst and pH regulation, so- susceptibility, genetic control, L15
L622 SUBJECT INDEX TO VOLUME 8
Inflammation (continued) Liposomes, increased surfactant internali- growth factor-@ expression and se-
susceptibility, separate loci control re- zation, type II cells, microporous cretion, L36
sponses, L21 membranes, L300 sodium and proton pump, respiratory
Inositol trisphosphate, norepinephrine-in- Lipoxygenase, activation of tracheal burst and pH regulation, L523
duced pulmonary arterial contrac- smooth muscle responsiveness, stimulation of chemotaxis, surfactant
tion, L160 FMLP-treated HL-60 cells, neutro- protein A, L338
Insulinoma, glucagon-like peptide-1 recep- phils, L222 TNF administration, superoxide pro-
tors, solubilization, lung, L146 Lung duction and protein kinase C activ-
Integrin, mediation of endothelial injury, adult respiratory distress syndrome ity, L43
neutrophil adherence to extracellu- PAF-induced alterations, pertussis alveolar epithelial cells and, transcellular
lar matrix, L401 toxin (pig), L213 eicosanoid synthesis, L438
Interleukin 1, -induced IL-6 production, PAF receptor antagonism, TNF-a and biliary cirrhosis, increased pulmonary
inhibition by cAMP, lung fibro- IL-la coinfusion (pig), L175 vascular resistance, role of throm-
blasts, L253 arterial myocytes boxane A», L245
Interleukin-la, tumor necrosis factor-a acute hypoxia, cytosolic calcium, L323 neutrophil-activating peptide-2, pulmo-
and, cardiopulmonary alterations, reduction of potassium currents, hy- nary edema, congestive heart failure
PAF receptor antagonism (pig), poxia, L116 or ARDS, L490
L175 calcium transients in type II alveolar epi- Manganese superoxide dismutase, expres-
Interleukin 6, IL-1-induced production, in- thelial cells, induction by pH, L448 sion, ovary cells (hamster), L598
hibition by cAMP, lung fibroblasts, Clara cell differentiation, secretory prod- Mannitol, oxidant injury, alteration of bar-
L253 uct expression during (rabbit, rat), rier function, tracheal epithelium
Interleukin 8, chemoattractant in sputum, L543 (ferret), L165
chronic inflammatory airway dis- epithelial cells Mannose-binding protein, stimulation of
eases, L413 amiloride-sensitive Na* channels, fe- chemotaxis by SP-A, alveolar mac-
Intestine, IEC-6 and CF nasal cells ex- tus, L357 rophages, L338
pressing CFTR, low-conductance quantitative evaluation, gene expres- Mast cells, histamine release, inhibition by
chloride channels, L229 sion, L199 heparin, L387
Ionic currents, pulmonary and mesenteric epithelium, regulation of phosphatidyl- Mastocytoma cells, histamine release from
arterial myocytes, primary culture choline synthesis, type II cells, L575 mast cells, inhibition by heparin,
and subculture, L107 fetal L387
Ions, transport, modulation by dexametha- modulation of differentiation by oxy- Mn SOD: see Manganese superoxide dis-
sone, fluid movement across airway gen, cAMP responsiveness, L465 mutase
epithelium, L376 trafficking of surfactant protein A, or- Monoclonal antibodies
Ischemia gan culture, L27 amiloride-sensitive Na* channels, fetal
lung tissue, adenine nucleotide degrada- type II cell differentiation, serum-free lung epithelial cells, L357
tion, L329 cell culture, L504 mediation of endothelial injury, neutro-
pulmonary venules, hydraulic conductiv- fibroblasts, IL-1-induced IL-6 produc- phil adherence to extracellular ma-
ity, L382 tion, inhibition by cAMP, L253 trix, L401
fibrosis, asbestos exposure, L276 Monocrotaline pyrrole, -induced DNA
K gastrin-releasing peptide receptors, con- cross-linking, pulmonary artery en-
tractile effect, bombesin, L80 dothelium (pig), L517
Kininase II, steroid-induced suppression of glucagon-like peptide-1 receptors, solu- Monocytes, chemotaxis, alveolar macro-
adhesion, reversal by peptidase in- bilization, L146 phage production, transforming
hibitors, tracheal blood vessels, hypertensive, vasoconstrictor suppres- growth factor-8 expression, L36
L316 sion by EDRF, L587 Monokines, pulmonary artery endothelial
hypoxic pulmonary hypertension, PDGF protein kinase C, activation by tu-
L A- and B-chain genes, L100 mor necrosis factor-a, L7
Lactate, O.-dependent modulation, pulmo- immature, growth of, transplanted into Monolayers, alveolar epithelial barrier
nary artery tone, L141 adult, L60 properties, asymmetric properties,
Lamellar bodies increased pulmonary vascular resistance, hydrogen peroxide, L308
stimulation of surfactant protein A syn- biliary cirrhosis, role of thrombox- Motoneurons, vagal, excitability, adeno-
thesis, ATP and cAMP, lung, L431 ane A», L245 sine-induced inhibition, L124
trafficking of surfactant protein A, fetal ischemic tissue, adenine nucleotide deg- Mucus, sputum, interleukin 8 as chemo-
lung, organ culture, L27 radation, L329 attractant, chronic inflammatory
Lectin, stimulation of chemotaxis by SP-A, matrix injury, fibronectin release airway diseases, L413
alveolar macrophages, L338 (sheep), L66 Muscarinic agonists, differences in Ca?*
Leukemia, promyelocytic, FMLP-treated pulmonary artery endothelial protein ki- mobilization, tracheal smooth mus-
HL-60 cells and neutrophils, activa- nase C cle, L53
tion, tracheal smooth muscle re- activation, tumor necrosis factor-a, L7 Muscle, preload and stimulation intensity,
L-arginine transport (pig), L351
sponsiveness, L222 acetylcholine release, airway cholin-
pulmonary SP-A, biphasic glucocorticoid
Leukocytes ergic nerves (horse), L269
regulation, inhibitory process, L236
polymorphonuclear Muscle, smooth
pulmonary surfactant protein A, stimu-
neutrophil adherence to extracellular airway
lation of chemotaxis, alveolar mac-
matrix, mediation of endothelial in- cholinergic innervation and musca-
rophages, L338
jury, L401 rinic receptor subtypes in (piglet),
stimulation of surfactant A synthesis,
reversal of steroid-induced suppres- L606
ATP and cyclic AMP, L431
sion, neutrophil adhesion, L316 electrically evoked ACh release, cal-
Lymph, lung, ED,-containing cellular fi-
susceptibility to ozone-induced inflam- cium channel mediation of (guinea
bronectin release, postoperative bac-
mation pig), L581
teremia (sheep), L66
separate loci control responses, L21 hydrogen peroxide-exposed, hydroxyl
subacute exposure, genetic control, radical effects, L566
M
L15 modulation of tone by hypoxia, role of
Leukotrienes, transcellular eicosanoid syn- Macrophages calcium entry (pig), L284
thesis, cocultures, alveolar epithelial alveolar muscarinic cholinergic stimulation,
cells and macrophages, L438 bleomycin stimulation, transforming calcium mobilization, L496
SUBJECT INDEX TO VOLUME 8 L623
substrates, myosin phosphorylation, adherence to extracellular matrix, me- vascular, reversal of steroid-induced
and stress in, L553 diation, endothelial injury, L401 suppression, neutrophil adhesion,
bronchial, contractile effect of bombesin, FMLP-treated HL-60 cells and, activa- L316
gastrin-releasing peptide receptors, tion, tracheal smooth muscle re- vascular injury with postoperative bacte-
L80 sponsiveness, L222 remia, ED,-containing cellular fibro-
guanine nucleotides, receptor-effector interleukin 8 as chemoattractant, spu- nectin release, lung lymph (sheep),
coupling, inhibition of oxidative en- tum, chronic inflammatory airway L66
ergy production, L1 diseases, L413 Permselectivity, alteration of barrier func-
neurai relaxation of bronchi, nitric oxide steroid-induced suppression of adhesion, tion, oxidant injury, tracheal epithe-
synthase inhibitor, L425 reversal by peptidase inhibitors, tra- lium (ferret), L165
norepinephrine-induced pulmonary arte- cheal blood vessels, L316 Pertussis toxin, attenuation, platelet-acti-
rial contraction, involvement of in- Nitric oxide, suppression, vasoconstrictor vating factor-induced pulmonary
ositol trisphosphate, L160 mechanism, hypertensive lung, L587 hemodynamic alterations (pig),
pulmonary and mesenteric arterial myo- Nitric oxide synthase, inhibitor, neural re- L213
cytes, ionic currents, primary cul- laxation, bronchi, L425 pH
ture and subculture, L107 N°- Nitro-L-arginine methyl ester, nitric induction, calcium transients in type II
tracheal oxide synthase inhibitor, neural re- alveolar epithelial cells, L448
activation, FMLP-treated HL-60 cells laxation, bronchi, L425 regulation and respiratory burst, sodium
and neutrophils, L222 Norepinephrine, -induced pulmonary arte- and proton pump, alveolar macro-
contraction, mode of activation of eo- rial contraction, involvement of ino- phages, L523
sinophils, L475 sitol trisphosphate, L160 Phorbol 12-myristate 13-acetate
differences in Ca** mobilization, mus- Nucleotides sodium and proton pump, respiratory
carinic agonists, L53 adenine, degradation, ischemic lung tis- burst and pH regulation, alveolar
vascular, Cu,Zn superoxide dismutase, sue, L329 macrophages, L523
cell cycling and exposure to hyper- cyclic, modulation of inherent airway TNF administration, superoxide produc-
oxia, L365 tone, phosphodiesterase isozymes, tion and protein kinase C activity,
Myocytes L458 alveolar macrophages, L43
pulmonary and mesenteric arterial, ionic Phosphatidylcholine, regulation of synthe-
currents, primary culture and sub- O sis, type II cells, fetal, L575
culture, L107 Ovary cells, Mn SOD expression in, oxi- Phosphatidylethanol, activation of phos-
pulmonary arterial dant injury protection (hamster), pholipase D, surfactant secreta-
acute hypoxia, cytosolic calcium, L323 L598 gogues, type II pneumocytes, L133
reduction of potassium currents, hy- Oxidants, alveolar epithelial barrier prop- Phosphodiesterase, isozymes, modulation
poxia, L116 erties, asymmetric properties, hy- of inherent tone, airway, L458
Myosin, phosphorylation, stress and sub- drogen peroxide, L308 Phospholipase A>
strates with, airway smooth muscle, Oxidant injury alveolar type II epithelial cells, biochem-
L553 alteration of barrier function, tracheal ical and immunologic characteriza-
epithelium (ferret), L165 tion, L261
N protection from, ovary cells (hamster), A23187-mediated activation of, serine
L598 esterase role in, pulmonary endothe-
Nasal mucosa, secretion, gastrin-releasing Oxygen lium, L538
peptide and analogues, L345 -dependent modulation, lactate, pulmo- Phospholipase D, activation by ATP, sur-
Nerve: see also specific nerve nary artery tone, L141 factant secretagogues, type II pneu-
airway cholinergic, acetylcholine release, modulation of differentiation, cAMP re- mocytes, L133
stimulation intensity and muscle sponsiveness, fetal lung, L465 Phospholipids, phospholipase A:, alveolar
preload (horse), L269 Ozone type II epithelial cells, characteriza-
relaxation of bronchi, nitric oxide syn- -induced inflammation tion, L261
thase inhibitor, L425 susceptibility, genetic control, L15 Phosphoramidon, steroid-induced suppres-
Neuraminidase, cell surface carbohydrates, susceptibility, separate loci control re- sion of adhesion, reversal of pepti-
modulation of neutrophil adherence, sponses, L21 dase inhibitors, tracheal blood ves-
alveolar type II cells, L391 sels, L316
Neuropeptides, gastrin-releasing peptide Pp Plasma membrane, amiloride-sensitive Na*
and analogues, nasal mucosal secre- PAF: see Platelet-activating factor channels, fetal lung epithelial cells,
tion, L345 Paraquat, oxidant injury, Mn SOD protec- L357
Neurotransmission, acetylcholine release tion from, ovary cells (hamster), Plasminogen, asbestos exposure, increased
from airway cholinergic nerves, L598 bronchial epithelial cell fibrinolytic
stimulation inieusity, muscle pre- Patch-clamp technique, reduction of potas- activity, L276
load (horse), L269 sium currents, hypoxia, pulmonary Platelet-activating factor, -induced pulmo-
Neurotransmitters arterial myocytes, L116 nary hemodynamic alterations, at-
constitutive hypersecretion and insensi- PDGF: see Platelet-derived growth factor tenuation, pertussis toxin (pig),
tivity, cystic fibrosis tracheal gland Peptidase, inhibitors, reversal of steroid- L213
cells, L93 induced suppression of adhesion, Platelet-derived growth factor, A- and B-
electrically evoked release, N-type cal- tracheal blood vessels, L316 chain genes, hypoxic pulmonary hy-
cium channel mediation of, trachea Peptides, vasoactive intestinal, neural re- pertension, lung, L100
(guinea pig), L581 laxation of bronchi, nitric oxide syn- Platelets, neutrophil-activating peptide-2,
Neutral endopeptidase, steroid-induced thase inhibitor, L425 pulmonary edema, congestive heart
suppression of adhesion, reversal by Permeability failure or ARDS, L490
peptidase inhibitors, tracheal blood ischemic pulmonary venules, hydraulic Pneumocytes
vessels, L316 conductivity, L382 alveolar type II epithelial cells, phospho-
Neutrophil-activating peptide-2, pulmo- mediation of endothelial injury, neutro- lipase Ao, characterization, L261
nary edema from congestive heart phil adherence to extracellular ma- amiloride-sensitive Na* channels, fetal
failure, ARDS, L490 trix, L401 lung epithelial cells, L357
Neutrophils susceptibility to ozone-induced inflam- increased surfactant internalization, type
adherence to alveolar type II cells, cell mation, subacute exposure, genetic II cells, microporous membranes,
surface carbohydrates, L391 control, L15 L300
L624 SUBJECT INDEX TO VOLUME 8
Pneumocytes (continued) muscarinic transport, air-liquid interface culture
type II differences in Ca”* mobilization, tra- system, L560
activation of phospholipase D, surfac- cheal smooth muscle, L53 Sodium-calcium exchanger, calcium tran-
tant secretagogues, L133 subtypes, development of, trachea sients in type II alveolar epithelial
hypertrophy after pneumonectomy, (piglet), L606 cells, induction by pH, L448
L153 muscarinic cholinergic, calcium mobili- Sodium channels, amiloride-sensitive, fetal
Polyclonal antibodies, amiloride-sensitive zation, airway smooth muscle, L496 lung epithelial cells, L357
Na* channels, fetal lung epithelial platelet-activating factor, antagonism, Sodium-hydrogen exchange, respiratory
cells, L357 cardiopulmonary alterations (pig), burst and pH regulation, alveolar
Polymerase chain reaction, quantitative L175 macrophages, L523
evaluation of gene expression, respi- solubilized lung GLP-1, L146 Steroids, -induced suppression of neutro-
ratory epithelial cells, L199 Reperfusion, ischemic pulmonary venules, phil adhesion, reversal by peptidase
Potassium currents hydraulic conductivity, L382 inhibitors, tracheal blood vessels,
pulmonary and mesenteric arterial myo- Respiratory burst, pH regulation and, so- L316
cytes, primary culture and subcul- dium and proton pump, alveolar Stress
ture, L107 macrophages, L523 heat, regulation of 70-kDa heat-shock
reduction of, hypoxia, pulmonary arterial Respiratory distress syndrome, adult, neu- gene, L533
myocytes, L116 trophil-activating peptide-2, pulmo- substrates, myosin phosphorylation and,
Prostaglandin E,, IL-1-induced IL-6 pro- nary edema, L490 airway smooth muscle, L553
duction, inhibition by cAMP, lung Ribonucleic acid, messenger Submucosal glands, gastrin-releasing pep-
fibroblasts, L253 alveolar macrophage production, trans- tide and analogues, nasal mucosal
Prostaglandins, transcellular eicosanoid forming growth factor-8, L36 secretion, L345
synthesis, cocultures, alveolar epi- biphasic glucocorticoid regulation, pul- Substrata, microporous membranes, in-
thelial cells and macrophages, L438 monary SP-A, inhibitory process, creased surfactant internalization,
Protein, synthesis, pulmonary arteries ex- L236 type II cells, L300
posed to hypoxia, L74 Cu,Zn superoxide dismutase, cell cycling Substrates, myosin phosphorylation, stress
Protein kinase C and exposure to hyperoxia, vascular and, airway smooth muscle, L553
pulmonary artery, activation by tumor cells, L365 Superoxide
necrosis factor-a, L7 hydrogen peroxide-induced increase, oxidant injury, alteration of barrier func-
superoxide production and, TNF admin- endothelial adhesiveness, ICAM-1 tion, tracheal epithelium (ferret),
istration, alveolar macrophages, L43 activation, L406 L165
Proteolysis quantitative evaluation of gene expres- production, TNF administration, alveo-
asbestos exposure, increased bronchial sion, respiratory epithelial cells, lar macrophages, L43
epithelial cell fibrinolytic activity, L199 Superoxide anions, O.-dependent modula-
L276 stimulation of surfactant protein A syn- tion, lactate, pulmonary artery tone,
cell-specific posttranslational processing, thesis, ATP and cyclic AMP, lung, L141
surfactant-associated protein SP-B, L431 Superoxide dismutase
L290 Cu,Zn, cell cycling and exposure to hy-
Proton pump, sodium pump and, respira- s peroxia, vascular cells, L365
tory burst and pH regulation, alveo- Sarcoplasmic reticulum, increased cytosolic oxidant injury, alteration of barrier func-
lar macrophages, L523 calcium, acute hypoxia, pulmonary tion, tracheal epithelium (ferret),
Pulmonary artery arterial myocytes, L323 L165
inositol trisphosphate, L160 Secretagogues variable glutathione levels, antioxidant
norepinephrine-induced contraction adenosine triphosphate, activation of enzymes, endothelial cells, L482
acute hypoxia, increased cytosolic cal- phospholipase D, type II pneumo- Surfactant
cium, L323 cytes, L133 biosynthesis, type II pneumocyte hyper-
endothelial cells, L-arginine transport increased surfactant internalization, type trophy, partial pneumonectomy,
(pig), L351 II cells, microporous membranes, L153
endothelial protein kinase C, activation L300 internalization by type II cells, micropo-
by tumor necrosis factor-a, L7 Septic shock, TNF administration, super- rous membranes, L300
exposure to hypoxia, protein synthesis, oxide production and protein kinase secretagogues, activation of phospholi-
L74 C activity, alveolar macrophages, pase D, type II pneumocytes, L133
mesenteric myocytes and, ionic currents, L43 type II cell differentiation, serum-free
primary culture and subculture, Serine esterase, activation of phospholi- cell culture, fetal lung, L504
L107 pase A, and, pulmonary endothe- Surfactant protein A
myocytes, hypoxia, reduction of potas- lium, L538 biphasic glucocorticoid regulation, inhib-
sium currents, L116 Serous cells, cystic fibrosis tracheal gland itory process, L236
O.-dependent modulation of tone, lac- cells, hypersecretion and insensitiv- modulation of differentiation by oxygen,
tate, L141 ity, neurotransmitters, L93 cAMP responsiveness, fetal lung,
Pulmonary edema: see Edema Sialic acid, cell surface carbohydrates, L465
Pyrrolizidine alkaloids, monocrotaline pyr- modulation of neutrophil adherence, stimulation of chemotaxis, alveolar mac-
role-induced DNA cross-linking, alveolar type II cells, L391 rophage, L338
pulmonary artery endothelium (pig), Signal transduction stimulation of synthesis, ATP and cyclic
L517 activation, pulmonary artery endothelial AMP, lung, L431
trafficking of, fetal lung, organ culture,
protein kinase C, tumor necrosis
L27
R factor-a, L7 Surfactant protein B, cell-specific post-
PAF, pulmonary hemodynamic altera-
translational processing, L290
Receptors tions (pig), L213
adenosine, inhibition, vagal motoneuron Snarf-1, calcium transientsin type II alveo-
excitability, L124 lar epithelial cells, induction by pH, Bi
-effector coupling, smooth muscle guan- L448
ine nucleotides, inhibition of oxida- Sodium 12-0-Tetradecanoylphorbol-13 acetate, ac-
tive energy production, L1 proton pump and, respiratory burst and tivation of phospholipase D, surfac-
gastrin-releasing peptide, contractile ef- PH regulation, alveolar macro- tant secretagogues, type II pneumo-
fect of bombesin, lung, L80 phages, L523 cytes, L133
SUBJECT INDEX TO VOLUME 8 L625
Thapsigargin, increased cytosolic calcium, responsiveness, FMLP-treated HL-60 Vasoconstriction, O.-dependent modula-
acute hypoxia, pulmonary arterial cells, neutrophils, L222 tion, lactate, pulmonary artery tone,
myocytes, L323 Transforming growth factor-8 L141
Thromboxane A, expression and secretion, bleomycin- Vasoconstrictors, suppression by EDRF,
increased pulmonary vascular resistance, stimulated alveolar macrophages, hypertensive lung, L587
biliary cirrhosis, L245 L36 Venules
PAF, pulmonary hemodynamic altera- type II cell differentiation, serum-free postcapillary, reversal of steroid-induced
tions (pig), L213 cell culture, fetal lung, L504 suppression, neutrophil adhesion,
TNF: see Tumor necrosis factor Transplantation, growth of immature lung L316
Trachea in adult recipient, L60 pulmonary, ischemia, hydraulic conduc-
airway cholinergic nerves, acetylcholine Tumor necrosis factor, superoxide produc- tivity, L382
release, stimulation intensity and tion and protein kinase C activity, Vero cells, IEC-6 and CF nasal cells ex-
muscle preload (horse), L269 alveolar macrophages, L43 pressing CFTR, low-conductance
blood vessels, steroid-induced suppres- Tumor necrosis factor-a chloride channels, L229
sion of adhesion, reversal by pepti- activation, pulmonary artery endothelial
dase inhibitors, L316 protein kinase C, L7 Ww
cholinergic innervation, muscarinic re- hydrogen peroxide-induced increase, WEB 2086
ceptor subtypes and (piglet), L606 endothelial adhesiveness, ICAM-1 biliary cirrhosis, increased pulmonary
contractile effect of bombesin, gastrin- activation, L406 vascular resistance, role of throm-
releasing peptide receptors, lung, interleukin-la and, cardiopulmonary al- boxane A», L245
L80 terations, PAF receptor antagonism PAF receptor antagonism, cardiopulmo-
cystic fibrosis, hypersecretion and insen- (pig), L175 nary alterations, TNF-a and IL-la
sitivity, neurotransmitters, L93 coinfusion (pig), L175
electrically evoked ACh release, N-type V Wound healing, tubule formation, three-di-
calcium channel mediation of mensional collagen lattice, surface
(guinea pig), L581 Vaccinia, IEC-6 and CF nasal cells ex- respiratory epithelial cells, L183
epithelium, alteration of barrier func- pressing CFTR, low-conductance
tion, oxidant injury (ferret), L165 chloride channels, L229 x
smooth muscle Vagus nerve
differences in Ca** mobilization, mus- motoneuron excitability, adenosine-in- Xanthine oxidase, alteration of barrier
carinic agonists, L53 duced inhibition, receptor subtype, function, oxidant injury, tracheal
hydrogen peroxide-exposed, hydroxyl L124 epithelium (ferret), L165
radical effects, L566 stimulation, development of, trachea
Z
mode of activation of eosinophils, (piglet), L606
L475 Vasculature, pulmonary, activation of Zinc, -Cu superoxide dismutase, cell cy-
muscarinic cholinergic stimulation, endothelial protein kinase C, tumor cling and exposure to hyperoxia,
calcium mobilization, L496 necrosis factor-a, L7 vascular cells, L365

Author Index to Volume 8
Acarregui, M. J., L465 Figarella, C., L93 Kolligs, F., L146 Papes, R., L598
Alcorn, J. L., L27 Fillers, W. S., L1 Kong, X.-J., L365 Parker, D. M., L7
Al-Hassani, M. H., L53 Fisher, A. B., L300, L431 Kruse-Elliott, K. T., L175, L213 Parker, K., L401
Atkinson, M. A. L., L490 Flameng, W., L329 Kulp, G. V. P., L475 Pavirani, A., L229
Aubier, M., L391 Flanagan, S., L533 Peters-Golden, M., L261, L438
Azim, S., L1 Forman, H. J., L523 Lacaze-Masmonteil, T., L504 Peterson, M. W., L276
BBaaik,e rT,. DR.. , G.L,4 2L55 81 FFurjaistlao,n ,H .C,. ,L 1L0500 4 LLLaaaicn,hk ,aL t.-,EB .,uL t4L0t81g0,e reLi4t0,6 B., L146 PPeettireyt,, TA.. , W.L,3 91L 517
BBBBBaaaaalurrrleoaaarnnnr,,iod uw,k sMC,k..P i .,B JL. ..L, ., , NS L..L,,1L3 25LL37236 24 25 GGGGGiaaeaeirrwslcbi,lion aat,r,Jh d. ,,-AJ P... D ,G. G.Z,. .L ,D8 L.N0L1,. 3 ,84 3L5L 4 5438 LLLLLaaeaanzcutzaowhircealugrlms,io,, j, n Js.DSJ,-...P , . JC,J..L .,,,2 L 9L2LL03233 69825 79 PPPPPPhiiliiitnoneltopkdln,peiie erpmrrtsMo,,,o .n nt R,PCeV. ..,. ,KAGG ....GL, ,,. 1 ,EL7. LL45,L75 3 3 4L 1356 4 3
Beers, M. F., L431 Gobran, L. I., L133 Lee, R., L60 Post, M., L575
Benali, R., L183 Goke, B., L146 Lee, S.-L., L365 Prasad, K., L566
Benos, D. J., L357 Goke, R., L146 Leff, A. R., L222, L475 Puchelle, E., L183
Benson, B., L290 Goldman, W. F., L107, L116, Lerut, T., L329
Bhattacharya, J., L382 L323 Levitt, R. C., L15, L21 Qiao, R.-L., L382
Bijman, J., L229 Greene, B., L351 Lewis, E., L66
Blaustein, M. P., L107, L116 Gross, T. J., L276 Liebig, S., L458 Rabe, K. F., L458
Borchelt, J., L290 Gruenert, D. C., L276 Lin, C., L357 Rebres, R., L66
Boucher, R. C., L560 Gunst, S. J., L53 Lipscomb, G. E., L43 Ren Hsiue, T., L475
Bourbon, J. R., L504 Gupta, J. B., L566 Lo, S. K., L406 Reyes, V., L553
Bramley, A. M., L425 Lundgren, J. D., L345 Rhoades, R. A., L160
Brown, J. K., L581 Haddad, E.-B., L380 Richman-Eisenstat, J. B. Y.,
Haddad, G. G., L124 Magnussen, H., L458 L413
Cardoso, W. V., L543 Hai, C.-M., L553 Malik, A. B., L401, L406 Richter, G., L146
Carlson, K. S., L575 Hamann, K. J., L222 Mandel, L. J., L560 Rinaldi, M., L60
Cattarossi, L., L606 Hasunuma, K., L587 Maqguart, F. X., L183 Rizk, T., L66
Chailley-Heu, B., L504 Hawgood, S., L290 Marin, M. G., L165 Robinson, N. E., L269
Chakraborti, S., L538 Haworth, S. G., L60 Marks, J. D., L124 Rodman, D. M., L587
Chang, S.-W., L245 Haxhiu, M. A., L606 Martin, R. J., L606 Rolland, C., L391
Chevillard, M., L183 Haxhiu-Poskurica, B., L606 Martin, T. R., L490 Rollins, S. M., L36
Chinoy, M. R., L300 Hébert, C. A., L413 Masuda, T., L376 Roman, R. J., L448
Cobb, S. M., L276 Heile, M., L598 Matalon, S., L357 Rooney, S. A., L133
Coburn, R. F., L1 Hinnrasky, J., L183 Matthay, M. A., L490 Roth, R. A., L517
Coflesky, J. T., L74 Hirshman, C. A., L284 Maunder, R. J., L490 Rubin, L. J., L107, L116
CCCCCorooozalhmzgaemiosn,ie-, n,L Psi.An,E .h . Ja .BrL,J. t.., ,L, 2 MJL.2r4N,.29,. ,0L L 73L 35971 HHHHiooosogolkago,nep ,v, e Ge.AMn .., E, . A .LA,R5. .,7,L 5 6L L025 2493 MMMMMcacccCyBGDaerrofrienf,dgae eolr,rAdt .,,y ,RM. C.D .. JK . .SG ,M..D ,. . ,L,AL 1 .46,LL3 553 L 316360 SSSSaaaaslbdavauka,rit s,ekT ri.r, Ha .,M, .R .,LC, . 3L L76G366.8 , 2 L323
Crestani, B., L391 Iannuzzi, D. M., L236 McKeown-Longo, P., L66 Sasaki, T., L376
Croxton, T. L., L284 Inase, N., L387 McMurtry, I. F., L587 Satoh, M., L376
Scholte, B., L229
Dalemans, W., L229 Ishihara, H., L376 Mendelson, C. R., L27, L465 Schreck, R. E., L387
Damm, D., L290 Jacobs, E. R., L448 Merten, M. D., L93 Schreinemakers, H., L329
De Jonge, H., L229 Janakidevi, K., L406 Michael, J. R., L538 Schudt, C., L458
De Leyn, P., L329 Ji, C., L543 Miller, E. J., L490 Shibahara, S., L100
Denholm, E. M., L36 Jin, N., L160 Miller, M. J., L606 Shimura, S., L376
Dent, G., L458 Johnson, A., L7 Mohazzab-H, K. M., L141 Shirato, K., L100
Dickman, K. G., L560 Johnson, L. G., L560 Moore, K. L., L560 Singh, G., L543
Dodam, J. R., L213 Jorens, P. G., L413 Mortelliti, M. P., L141 Smith, B. T., L575
Dodia, C., L300, L431 Jornot, L., L482 Moseley, P. L., L533 Snyder, J. M., L465
Don, H. F., L581 Junod, A. F., L482 Mullenbach, G., L490 Solway, J., L222
Donnelly, D. F., L124 Munoz, N. M., L222 Souba, W. W., L351
Dreyer, D., L229 Kajita, J., L496 Murphy, J. K., L523 Spitz, D., L598
Effros, R. M., L448 Kaliner, M., L345 Nadel, J. A., L316, L413 Spitzer, J. A., L43
Elias, J. A., L253 Kansen, M., L229 Neagos, G. R., L261 Stelzner, T. J., L587
English, D., L160 Kaslovsky, R. A., L401 Stevens, M. D., L490
Ernsberger, P., L606 Katayama, M., L316 O’Brodovich, H., L357 Stewart, L. G., L543
Ertsey, R., L236 Katayose, D., L100 Ogata, M., L100 Stirewalt, W. S., L74
EEtvtaenrs,, MJ.. DN..,, LL7145 3 KKaetryna,l ,J . SA.. ,L .,L 5L3534 3 OOhhea,r a,M .,N .,L 1L0204 5 SSttroenke,, MK.. KE..,, LL417655
Keulemans, J., L229 Oka, M., L587 Stuart-Smith, K., L284
Fanburg, B. L., L365 Kim, E., L553 Olson, N. C., L175, L213 Suh, D.-J., L308
Feinstein, S. I., L431 Kim, K.-J., L308 Omar, H. A., L141
Fernandes, L. B., L284 Kleeberger, S. R., L15, L21 Takishima, T., L100, L376
Ferro, T. J., L7 Kleyman, T. R., L357 Pacitti, A. J., L351 Tenor, H., L458
Feyssa, A., L261, L438 Klossek, J. M., L183 Packer, C. S., L160 Thurlbeck, W. M., L543
L627
L628 AUTHOR INDEX TO VOLUME 8
Tod, M. L., L107, L116 Wagner, J. G., L517 Wilke, M., L229 Young, L. H., L74
Tournier, J. M., L183 Wali, A., L431 Williams, F. S., L475 Yu, M., L269
Trapnell, B. C., L199 Wallach, S. J., L553 Wispé, J., L598 Yuan, X.-J., L107, L116
UUehkail,, LB.., LD4.,1 3L 153 WWWaaarlnnlgee,nr ,, Z.E,B. . L, S2.L6,59 9 L85 33 WWroilgihnt,, MJ.. RS..,, LL124910 , L338 ZZhaahnmg,, JL.. -MY..,, LL11853, L21
Van Belle, H., L329 Watson, C., L553 Xu, J., L553 Zheng, T., L253
Van Lommel, F., L329 Webb, S. A., L587 Zimmermann, L. J., L575
Verbeek, E., L229 White, S. R., L475 Yamada, K., L376 Zitnik, R. J., L253
Verbeken, E., L329 White, T., L290 Yamaguchi, H., L496 Zupan, V., L504
Vincent, P., L66 Whorton, A. R., L213 Yamauchi, K., L100
Vita, A., L222 Wiener-Kronish, J. P., L490 Youmans, D. C., L338